Pro Picks: Regeneron Is a Cash Cow + 4 More to Plump Your Portfolio
Investing.com | May 19, 2023 22:40
If you’ve been scouring for uber-healthy companies to bulk up your portfolio, look no further. This week, our curated VIP list of Pro Picks - only available to InvestingPro subscribers - has five stocks with incredible cash flow health, making them primed to beat the S&P 500. Regeneron (NASDAQ:REGN), a cash-rich biotech giant, ranks elite among them.
All of this week’s Pro Picks sport cream-of-the-crop cash metrics such as a solid cash flow margin and debt-to-capital ratio. That means they’re in an excellent position not only to foot their bills, but to provide serious returns to fundamental investors.
Backed with all that cash, it’s clear why InvestingPro awarded these companies with a “Great Performance” health score of 2.75 or more. And for the last 7 years, stocks with these kinds of health scores have actually outperformed the market.
REGN is flush with cash, giving the company a lot of cushion to seed future growth. The company also just announced positive late-phase results on a new indication for its existing asthma drug, Dupixent, which research firm Jefferies believes could be a $4B opportunity for REGN.
Shares took a hit earlier this month after the company trimmed its gross margin guidance, knocking the stock down to a tempting price: At these levels, analysts expect some 20% upside, while InvestingPro fair value anticipates a rise of about 27%.
Want to see the full list of this month's Pro Picks poised to beat the market? Start a 7-day free trial to unlock must-have insights and data.
If you're already an InvestingPro subscriber, this week's full Pro Picks list is available here .
Data as of May 18, 2023
Get The App
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.